Cargando…
Nuclear Factor Erythroid 2-Related Factor 2 Activation Might Mitigate Clinical Symptoms in Friedreich’s Ataxia: Clues of an “Out-Brain Origin” of the Disease From a Family Study
Friedreich’s ataxia (FRDA) is the most frequent autosomal recessive ataxia in western countries, with a mean age of onset at 10–15 years. Patients manifest progressive cerebellar and sensory ataxia, dysarthria, lower limb pyramidal weakness, and other systemic manifestations. Previously, we describe...
Autores principales: | Petrillo, Sara, Santoro, Massimo, La Rosa, Piergiorgio, Perna, Alessia, Gallo, Maria Giovanna, Bertini, Enrico Silvio, Silvestri, Gabriella, Piemonte, Fiorella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940825/ https://www.ncbi.nlm.nih.gov/pubmed/33708070 http://dx.doi.org/10.3389/fnins.2021.638810 |
Ejemplares similares
-
Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
por: Petrillo, Sara, et al.
Publicado: (2019) -
The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
por: La Rosa, Piergiorgio, et al.
Publicado: (2019)